SEC Form 4 · accession 0001209191-15-015868
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Condella Jr.
Officer — President & CEO
Period of report
Feb 11, 2015
Accepted (ET)
Feb 19, 2015 · 12:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy)F1 | $5.56 | Feb 11, 2015 | A | 40,000 | A | May 11, 2015 | Feb 11, 2022 | $0.01 par value of Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F11. The option will become exercisable in 8.33% increments of the shares on each quarterly anniversary of the date of grant.